On March 17, 2023, two bipartisan pieces of legislation were introduced to the U.S. House of Representatives with the goal of requiring the U.S. Food and Drug Administration (FDA) to regulate cannabidiol (CBD) products in foods and dietary supplements. 

The U.S. Senate has introduced a bill that would enforce stricter regulation of the Generally Recognized as Safe (GRAS) rule and that calls for the creation of a new office within the U.S. Food and Drug Administration that would assess chemicals in food.